isoniazid has been researched along with fluconazole in 53 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (5.66) | 18.2507 |
2000's | 8 (15.09) | 29.6817 |
2010's | 37 (69.81) | 24.3611 |
2020's | 5 (9.43) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Adamec, J; Beckert, R; Buchta, V; Kaustová, J; Klimesová, V; Möllmann, U; Waisser, K; Weiss, D | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Buchta, V; Férriz, JM; Imramovský, A; Jampílek, J; Vinsová, J | 1 |
Chandrashekar, SM; Mallikarjuna, BP; Rajendraprasad, Y; Sastry, BS; Sathisha, K; Suresh Kumar, GV | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Campillo, NE; Guerra, A; Páez, JA | 1 |
Chandrashekar, SM; Kistayya, C; Mallikarjuna, BP; Rajendraprasad, Y; Suresh Kumar, GV | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Chandrashekar, SM; Mallikarjuna, BP; Rajendra Prasad, Y; Suresh Kumar, GV | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Bösze, S; Buchta, V; Horvati, K; Krátký, M; Stolaříková, J; Vinšová, J | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Arshad, A; Bagley, MC; Lam, CK; Mohamad, S; Osman, H; Zahariluddin, AS | 1 |
Ahsan, MJ; Gaur, R; Khalilullah, H; Nomani, MS; Samy, JG; Saraswat, P; Singh, A | 1 |
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
Barad, HA; Gupta, VK; Kant, R; Pansuriya, BR; Parmar, NJ | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Coffey, A; Csollei, J; Fajkusova, D; Guo, J; Jampilek, J; Keltosova, S; Kollar, P; Kralova, K; Oktabec, Z; Pesko, M; Vejsova, M | 1 |
Doležal, M; Kubíček, V; Kuneš, J; Paterová, P; Servusová, B; Vobicková, J; Zitko, J | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Buchta, V; Kozic, J; Krátký, M; Mandíková, J; Stolaříková, J; Trejtnar, F; Vinšová, J | 1 |
Anand, N; Chaturvedi, V; Dwivedi, AK; Gupt, MP; Gupta, V; Kumar, B; Lal, J; Pandey, S; Pandey, SK; Rai, N; Ramachandran, R; Ramakrishna, KK; Sharma, P; Shukla, PK; Singh, S; Srivastava, KK; Tripathi, RP | 1 |
Dufková, I; Hrabálek, A; Karabanovich, G; Klimešová, V; Němeček, J; Pávek, P; Roh, J; Smutný, T; Stolaříková, J; Vávrová, K; Vejsová, M; Vicherek, P | 1 |
Krátký, M; Novotná, E; Stolaříková, J; Trejtnar, F; Vinšová, J; Volková, M | 1 |
Baranyai, Z; Bősze, S; Krátký, M; Paraskevopoulos, G; Stolaříková, J; Szabó, I; Vinšová, J | 1 |
Bharate, SS; Vishwakarma, RA | 1 |
Achur, R; Dalimba, U; Kumar, HS; Nayak, N; Peethambar, SK; Ramprasad, J; Sriram, D; Yogeeswari, P | 1 |
Besra, G; Krátký, M; Mandíková, J; Paraskevopoulos, G; Pávek, P; Stolaříková, J; Trejtnar, F; Vinšová, J | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Carazo, A; Hrabálek, A; Karabanovich, G; Klimešová, V; Konečná, K; Němeček, J; Pávek, P; Pavliš, O; Roh, J; Stolaříková, J; Valášková, L; Vávrová, K | 1 |
Krátký, M; Stolaříková, J; Vinšová, J | 1 |
Benková, M; Hrabálek, A; Karabanovich, G; Kavková, V; Klimešová, V; Konečná, K; Macháček, M; Němeček, J; Roh, J; Soukup, O; Stolaříková, J; Sychra, P; Vávrová, K | 1 |
Baranyai, Z; Bősze, S; Krátký, M; Stolaříková, J; Vinšová, J | 1 |
Alajlani, M; Bauer, R; Belaj, F; Brantner, A; Bucar, F; Faist, J; Hochegger, P; Kaiser, M; Kretschmer, N; Mäser, P; Mohsin, NU; Saf, R; Seebacher, W; Turek, I; Weis, R | 1 |
De Coen, LM; Gemili, M; Nural, Y; Sahin, E; Sari, H; Ulger, M | 1 |
Ashok, D; Goud, GL; Manga, V; Ramesh, S; Reddy, VP; Saikrishna, B; Sriram, D; Yogeeswari, P | 1 |
Augustynowicz-Kopeć, E; Bojanowski, K; Foks, H; Gobis, K; Głogowska, A; Korona-Głowniak, I; Krause, M; Siluk, D; Ziembicka, D | 1 |
Dixit, PP; Haval, KP; Haval, NB; Kasare, SL; Khedkar, VM; Patil, PS; Rekha, EM; Sriram, D | 1 |
Agafonova, NA; Borisevich, SS; Burgart, YV; Chupakhin, ON; Evstigneeva, NP; Gerasimova, NA; Krasnykh, OP; Kungurov, NV; Kushch, SO; Makhaeva, GF; Maslova, VV; Rudakova, EV; Saloutin, VI; Shchegolkov, EV; Solodnikov, SY; Triandafilova, GA; Ulitko, MV; Zilberberg, NV | 1 |
Bayannavar, PK; Hoolageri, SR; Joshi, SD; Kamble, RR; Kodasi, B; Kumbar, VM; Nesaragi, AR; Shaikh, SKJ | 1 |
Teira, R | 1 |
Bowersox, J | 1 |
Naidong, W; Shou, WZ | 1 |
Brilhante, RS; Cordeiro, Rde A; de Camargo, ZP; de Lima, RA; Medrano, DJ; Monteiro, AJ; Rocha, MF; Sidrim, JJ; Tavares, JL | 1 |
Aberg, J; Powderly, W | 1 |
Brilhante, RS; Caetano, EP; Castelo-Branco, Dde S; Cordeiro, Rde A; de Lima, RA; Fechine, MA; Marques, FJ; Mesquita, JR; Monteiro, AJ; Mourão, CI; Ribeiro, JF; Rocha de Castro E Silva, K; Rocha, FA; Rocha, MF; Sidrim, JJ | 1 |
Gallo, A; Hurwitz, M; Hwang, C; Mojtahed, A; Whitney, J | 1 |
Bandeira, Tde J; Brilhante, RS; Cordeiro, Rde A; de Melo, CV; Evangelista, AJ; Marques, FJ; Mota, VF; Rocha, MF; Serpa, R; Sidrim, JJ | 1 |
Ahmed, M; Ali, M; Ayatollahi, SA; Esfahanizadeh, M; Haider, SM; Hasan, A; Khan, KM; Kobarfard, F | 1 |
Azmi, MN; Che Omar, MT; Osman, H; Parumasivam, T; Supratman, U; Wong, KT | 1 |
2 review(s) available for isoniazid and fluconazole
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
HIV: primary and secondary prophylaxis for opportunistic infections.
Topics: AIDS-Related Opportunistic Infections; Fluconazole; HIV Infections; Humans; Isoniazid; Opportunistic Infections; Trimethoprim, Sulfamethoxazole Drug Combination | 2010 |
51 other study(ies) available for isoniazid and fluconazole
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Hybrid molecules of estrone: new compounds with potential antibacterial, antifungal, and antiproliferative activities.
Topics: Anti-Bacterial Agents; Antifungal Agents; Antineoplastic Agents; Antitubercular Agents; Bacteria; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chromatography, Thin Layer; Estrone; Fungi; Heterocyclic Compounds; Humans; Indicators and Reagents; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Spectrophotometry, Infrared | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Salicylanilide esters of N-protected amino acids as novel antimicrobial agents.
Topics: Absidia; Amino Acids; Anti-Infective Agents; Aspergillus fumigatus; Esters; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Salicylanilides; Trichophyton | 2009 |
Synthesis of new 4-isopropylthiazole hydrazide analogs and some derived clubbed triazole, oxadiazole ring systems--a novel class of potential antibacterial, antifungal and antitubercular agents.
Topics: Anti-Bacterial Agents; Antifungal Agents; Antitubercular Agents; Bacteria; Cell Line, Tumor; Cell Survival; Fungi; Humans; Hydrazines; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship; Thiazoles | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Synthesis of some novel 2-substituted-5-[isopropylthiazole] clubbed 1,2,4-triazole and 1,3,4-oxadiazoles as potential antimicrobial and antitubercular agents.
Topics: Anti-Bacterial Agents; Antineoplastic Agents; Antitubercular Agents; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; Humans; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Oxadiazoles; Stereoisomerism; Structure-Activity Relationship; Thiazoles; Triazoles | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
Synthesis and pharmacological evaluation of clubbed isopropylthiazole derived triazolothiadiazoles, triazolothiadiazines and mannich bases as potential antimicrobial and antitubercular agents.
Topics: Anti-Infective Agents; Antitubercular Agents; Bacteria; Fungi; Magnetic Resonance Spectroscopy; Mass Spectrometry; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Spectrophotometry, Infrared; Thiazoles | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
New amino acid esters of salicylanilides active against MDR-TB and other microbes.
Topics: Amino Acids; Anti-Bacterial Agents; Antifungal Agents; Bacteria; Dose-Response Relationship, Drug; Drug Design; Esters; Extensively Drug-Resistant Tuberculosis; Fungi; Microbial Sensitivity Tests; Molecular Structure; Salicylanilides; Stereoisomerism; Structure-Activity Relationship; Tuberculosis, Multidrug-Resistant | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Synthesis and antimicrobial properties of some new thiazolyl coumarin derivatives.
Topics: Anti-Infective Agents; Candida albicans; Coumarins; Crystallography, X-Ray; Gram-Negative Bacteria; Gram-Positive Bacteria; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Models, Molecular; Mycobacterium tuberculosis; Spectrophotometry, Infrared; Thiazoles | 2011 |
Molecular properties prediction and synthesis of novel 1,3,4-oxadiazole analogues as potent antimicrobial and antitubercular agents.
Topics: Administration, Oral; Anti-Infective Agents; Antitubercular Agents; Bacteria; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oxadiazoles; Software; Structure-Activity Relationship | 2011 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
An improved microwave assisted one-pot synthesis, and biological investigations of some novel aryldiazenyl chromeno fused pyrrolidines.
Topics: Antifungal Agents; Antitubercular Agents; Aspergillus fumigatus; Azo Compounds; Benzopyrans; Candida albicans; Crystallography, X-Ray; Gram-Negative Bacteria; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Microwaves; Molecular Structure; Mycobacterium tuberculosis; Pyrrolidines; Stereoisomerism; Thiosemicarbazones | 2012 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Anti-infective and herbicidal activity of N-substituted 2-aminobenzothiazoles.
Topics: Anti-Infective Agents; Antifungal Agents; Antineoplastic Agents; Benzothiazoles; Cell Line, Tumor; Chloroplasts; Drug Screening Assays, Antitumor; Herbicides; Humans; Microbial Sensitivity Tests; Spinacia oleracea; Structure-Activity Relationship | 2012 |
Synthesis and antimycobacterial evaluation of N-substituted 5-chloropyrazine-2-carboxamides.
Topics: Amides; Anti-Bacterial Agents; Antitubercular Agents; Mycobacterium tuberculosis; Pyrazines; Structure-Activity Relationship | 2013 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Salicylanilide diethyl phosphates: synthesis, antimicrobial activity and cytotoxicity.
Topics: Anti-Bacterial Agents; Antifungal Agents; Antineoplastic Agents; Bacteria; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Fungi; Hep G2 Cells; Humans; Microbial Sensitivity Tests; Molecular Structure; Organophosphates; Salicylanilides; Structure-Activity Relationship | 2014 |
Identification of 1-[4-Benzyloxyphenyl)-but-3-enyl]-1H-azoles as New Class of Antitubercular and Antimicrobial Agents.
Topics: | 2013 |
1-Substituted-5-[(3,5-dinitrobenzyl)sulfanyl]-1H-tetrazoles and their isosteric analogs: A new class of selective antitubercular agents active against drug-susceptible and multidrug-resistant mycobacteria.
Topics: Antineoplastic Agents; Antitubercular Agents; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Resistance, Multiple, Bacterial; Drug Screening Assays, Antitumor; HeLa Cells; Hep G2 Cells; Humans; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Nitrobenzenes; Structure-Activity Relationship; Triazoles; Tumor Cells, Cultured | 2014 |
Synthesis and biological activity of new salicylanilide N,N-disubstituted carbamates and thiocarbamates.
Topics: Anti-Infective Agents; Carbamates; Cell Survival; Fungi; Gram-Positive Bacteria; Hep G2 Cells; Humans; Isocitrate Lyase; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mycobacterium avium; Mycobacterium kansasii; Salicylanilides; Structure-Activity Relationship; Thiocarbamates | 2014 |
Synthesis and in vitro biological evaluation of 2-(phenylcarbamoyl)phenyl 4-substituted benzoates.
Topics: Anti-Bacterial Agents; Antifungal Agents; Bacteria; Bacterial Infections; Benzoates; Fungi; Humans; Mycobacterium; Mycobacterium Infections; Mycobacterium tuberculosis; Mycoses; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2015 |
Thermodynamic equilibrium solubility measurements in simulated fluids by 96-well plate method in early drug discovery.
Topics: Drug Discovery; Pharmaceutical Preparations; Solubility; Thermodynamics | 2015 |
Synthesis and biological evaluation of new imidazo[2,1-b][1,3,4]thiadiazole-benzimidazole derivatives.
Topics: Animals; Antifungal Agents; Antioxidants; Antitubercular Agents; Benzimidazoles; Cell Survival; Chlorocebus aethiops; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Structure-Activity Relationship; Thiadiazoles; Tuberculosis; Vero Cells | 2015 |
Novel derivatives of nitro-substituted salicylic acids: Synthesis, antimicrobial activity and cytotoxicity.
Topics: Anti-Infective Agents; Cell Survival; Enterococcus; Fungi; Hep G2 Cells; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Salicylanilides; Salicylates; Staphylococcus; Structure-Activity Relationship | 2015 |
S-substituted 3,5-dinitrophenyl 1,3,4-oxadiazole-2-thiols and tetrazole-5-thiols as highly efficient antitubercular agents.
Topics: Antifungal Agents; Antitubercular Agents; Drug Design; Drug Resistance; Hep G2 Cells; Humans; Microbial Sensitivity Tests; Oxadiazoles; Structure-Activity Relationship; Sulfhydryl Compounds; Tetrazoles | 2017 |
Antimicrobial activity of rhodanine-3-acetic acid derivatives.
Topics: Acetic Acid; Anti-Infective Agents; Candida; Carbon-13 Magnetic Resonance Spectroscopy; Gram-Positive Bacteria; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Proton Magnetic Resonance Spectroscopy; Rhodanine; Spectrophotometry, Infrared | 2017 |
Structure-activity relationship studies on 3,5-dinitrophenyl tetrazoles as antitubercular agents.
Topics: Antitubercular Agents; Drug Resistance, Multiple; Humans; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Species Specificity; Structure-Activity Relationship; Tetrazoles | 2017 |
Synthesis and biological evolution of hydrazones derived from 4-(trifluoromethyl)benzohydrazide.
Topics: Animals; Anti-Infective Agents; Candida glabrata; Cell Line; Cell Survival; Hep G2 Cells; Humans; Hydrazones; Mice; Microbial Sensitivity Tests; Mycobacterium avium Complex; Mycobacterium kansasii; Mycobacterium tuberculosis | 2017 |
Synthesis of new 1-benzyl tetrahydropyridinylidene ammonium salts and their antimicrobial and anticellular activities.
Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; Antineoplastic Agents; Antiprotozoal Agents; Bacteria; Benzyl Compounds; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Mice; Microbial Sensitivity Tests; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium falciparum; Pyridines; Quaternary Ammonium Compounds; Rats; Saccharomyces cerevisiae; Salts; Structure-Activity Relationship; Trypanosoma brucei rhodesiense | 2018 |
Synthesis, antimicrobial activity and acid dissociation constants of methyl 5,5-diphenyl-1-(thiazol-2-yl)pyrrolidine-2-carboxylate derivatives.
Topics: Anti-Bacterial Agents; Antifungal Agents; Bacteria; Cycloaddition Reaction; Dose-Response Relationship, Drug; Fungi; Microbial Sensitivity Tests; Molecular Structure; Pyrrolidines; Structure-Activity Relationship; Thiazoles | 2018 |
Design, synthesis, molecular-docking and antimycobacterial evaluation of some novel 1,2,3-triazolyl xanthenones.
Topics: | 2017 |
4-Substituted picolinohydrazonamides as a new class of potential antitubercular agents.
Topics: Animals; Antitubercular Agents; Bacteria; Humans; Mice; Microbial Sensitivity Tests; Molecular Structure; Pyridines; Thiosemicarbazones; Yeasts | 2020 |
Novel isoniazid embedded triazole derivatives: Synthesis, antitubercular and antimicrobial activity evaluation.
Topics: Animals; Antifungal Agents; Antitubercular Agents; Aspergillus niger; Bacterial Proteins; Drug Design; Gram-Negative Bacteria; Isoniazid; Mice; Microbial Sensitivity Tests; Molecular Docking Simulation; Mycobacterium tuberculosis; Oxidoreductases; Protein Binding; RAW 264.7 Cells; Triazoles | 2020 |
Multiple biological active 4-aminopyrazoles containing trifluoromethyl and their 4-nitroso-precursors: Synthesis and evaluation.
Topics: Animals; Bacteria; Drug Screening Assays, Antitumor; Epidermophyton; HeLa Cells; Humans; Mice; Microbial Sensitivity Tests; Molecular Structure; Nitroso Compounds; Pyrazoles; Rats, Sprague-Dawley; Structure-Activity Relationship; Trichophyton | 2020 |
Microwave assisted regioselective synthesis of quinoline appended triazoles as potent anti-tubercular and antifungal agents via copper (I) catalyzed cycloaddition.
Topics: Antifungal Agents; Antitubercular Agents; Aspergillus; Candida albicans; Catalysis; Cell Survival; Copper; Cycloaddition Reaction; Dose-Response Relationship, Drug; HEK293 Cells; Humans; Microbial Sensitivity Tests; Microwaves; Molecular Structure; Mycobacterium tuberculosis; Quinolines; Stereoisomerism; Structure-Activity Relationship; Triazoles | 2021 |
Drugs for AIDS and associated infections.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Antiprotozoal Agents; Antiviral Agents; Atovaquone; Candidiasis, Oral; Clindamycin; Clotrimazole; Cryptosporidiosis; Cytomegalovirus Infections; Dapsone; Didanosine; Drug Combinations; Drug Therapy, Combination; Fluconazole; Flucytosine; Folic Acid Antagonists; Foscarnet; Glucuronates; Herpes Simplex; Herpes Zoster; Humans; Isoniazid; Itraconazole; Ketoconazole; Lamivudine; Mycobacterium avium-intracellulare Infection; Naphthoquinones; Nystatin; Pentamidine; Pneumocystis Infections; Pneumonia, Pneumocystis; Prednisone; Primaquine; Reverse Transcriptase Inhibitors; Stavudine; Syphilis; Toxoplasmosis; Trimetrexate; Tuberculosis; Zalcitabine; Zidovudine | 1995 |
[Treatment and prevention of main infections associated with HIV].
Topics: Adrenal Cortex Hormones; Amphotericin B; Controlled Clinical Trials as Topic; Cryptococcosis; Fluconazole; HIV Infections; Humans; Isoniazid; Pneumonia, Pneumocystis; Prospective Studies; Tuberculosis | 1994 |
CPCRA researchers present OI studies at Vancouver.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Antitubercular Agents; Candidiasis; Child; Clarithromycin; Clinical Trials as Topic; DNA, Viral; Drug Therapy, Combination; Ethambutol; Female; Fluconazole; Humans; Isoniazid; Molluscum Contagiosum; Molluscum contagiosum virus; Multicenter Studies as Topic; Mycobacterium avium-intracellulare Infection; Ofloxacin; Patient Compliance; Pyrazinamide; Rifampin; Sequence Analysis, DNA; Tuberculosis | 1996 |
Simple means to alleviate sensitivity loss by trifluoroacetic acid (TFA) mobile phases in the hydrophilic interaction chromatography-electrospray tandem mass spectrometric (HILIC-ESI/MS/MS) bioanalysis of basic compounds.
Topics: Acetic Acid; Chromatography, Liquid; Cotinine; Ethionamide; Fluconazole; Humans; Isoniazid; Nicotine; Piperazines; Propionates; Purines; Pyrazinamide; Sensitivity and Specificity; Sildenafil Citrate; Spectrometry, Mass, Electrospray Ionization; Sulfones; Trifluoroacetic Acid | 2005 |
In vitro synergistic effects of antituberculous drugs plus antifungals against Coccidioides posadasii.
Topics: Amphotericin B; Antifungal Agents; Antitubercular Agents; Caspofungin; Coccidioides; Coccidioidomycosis; Drug Synergism; Echinocandins; Ethambutol; Fluconazole; Humans; Isoniazid; Itraconazole; Ketoconazole; Lipopeptides; Microbial Sensitivity Tests; Pyrazinamide; Pyrimidines; Triazoles; Voriconazole | 2009 |
Synergistic effect of antituberculosis drugs and azoles in vitro against Histoplasma capsulatum var. capsulatum.
Topics: Antitubercular Agents; Drug Combinations; Drug Interactions; Ethambutol; Fluconazole; Histoplasma; Isoniazid; Itraconazole; Pyrazinamide; Pyrimidines; Triazoles; Voriconazole | 2011 |
Acute liver failure in a pediatric patient with disseminated tuberculosis.
Topics: Antifungal Agents; Antitubercular Agents; Child; Coccidioidomycosis; Drug Therapy, Combination; Ethambutol; Fluconazole; Humans; Isoniazid; Liver Failure, Acute; Male; Pyrazinamide; Recovery of Function; Rifampin; Tuberculosis, Multidrug-Resistant | 2011 |
Inhibitory activity of isoniazid and ethionamide against Cryptococcus biofilms.
Topics: Antifungal Agents; Biofilms; Cell Membrane Permeability; Cryptococcus gattii; Cryptococcus neoformans; Ergosterol; Ethionamide; Fluconazole; Isoniazid; Microbial Sensitivity Tests | 2015 |
Short Communication - Synthesis of drug metal complexes and their influence on human platelet aggregation.
Topics: Coordination Complexes; Drug Evaluation, Preclinical; Fluconazole; Humans; Isoniazid; Losartan; Metformin; Platelet Aggregation; Platelet Aggregation Inhibitors; Pyrazinamide | 2018 |
Synthesis, Characterization and Biological Evaluation of New 3,5-Disubstituted-Pyrazoline Derivatives as Potential Anti-
Topics: 14-alpha Demethylase Inhibitors; Antitubercular Agents; Bacterial Proteins; Catalytic Domain; Fluconazole; Isoniazid; Microbial Sensitivity Tests; Molecular Docking Simulation; Mycobacterium tuberculosis; Protein Binding; Protein Conformation; Protein Interaction Domains and Motifs; Pyrazoles; Semicarbazides; Sterol 14-Demethylase; Structural Homology, Protein; Thermodynamics | 2021 |